Literature DB >> 3943925

Suppression of human lymphocyte mitogen response by proteins of the type-D retrovirus PMFV.

J Denner, V Wunderlich, D Bierwolf.   

Abstract

A type-D retrovirus, derived from a human cell line and designated PMFV, which is related to, but distinct from the Mason-Pfizer monkey virus (MPMV) suppressed the in vitro mitogen response of human lymphocytes. PMFV was suppressive either as intact virus or after disruption by ether or detergents. In kinetic studies, the time course of the interaction between suppressive virus components and lymphocytes was characterized. Neither cytotoxicity nor time shifts in optimum 3H-thymidine incorporation of responding lymphocytes were observed. The suppressive activity of the disrupted virus was diminished by heating, freeze-thawing or treatment with pronase or trypsin, indicating temperature-sensitive proteins as suppressive components. By Sephacryl S-200 gel chromatography, molecular weights of approximately 70 and 15 kDa were determined for the suppressive components which were isolated from disrupted virus or virus-producing cells but not from non-infected cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943925     DOI: 10.1002/ijc.2910370221

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

Review 1.  Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

Authors:  R G Olsen; M G Lewis; L J Lafrado; L E Mathes; K Haffer; R Sharpee
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Suppression of human lymphocyte mitogen response by retroviruses of type D. I. Action of highly purified intact and disrupted virus.

Authors:  J Denner; V Wunderlich; G Sydow
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 3.  'There and back again': revisiting the pathophysiological roles of human endogenous retroviruses in the post-genomic era.

Authors:  Gkikas Magiorkinis; Robert Belshaw; Aris Katzourakis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-08-12       Impact factor: 6.237

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.